Theranostics approach in drug development: is there study efficiency when the prevalence of the molecular target is very high?
作者信息
Wang Sue-Jane, Fotenos Anthony, Masters Shane C, Marzella Louis
机构信息
Division of Biometrics I, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.
Division of Imaging and Radiation Medicine, Office of Specialty Medicine, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.
出版信息
Theranostics. 2022 Mar 28;12(7):3079-3083. doi: 10.7150/thno.71788. eCollection 2022.
Abstract
摘要
Zotero 插件